Search Results for 'her2'

her2 published presentations and documents on DocSlides.

HER2 and Ki67Assessment of regional lymph nodesPhysical examination

HER2 and Ki67Assessment of regional lymph nodesPhysical examination

by arya

Luminal B-like (HER2-positive):!ER-positive!HER2-p...

HER2 positive breast carcinoma in the pre and post adjuvant anti-HER-2 therapy era: a single academ

HER2 positive breast carcinoma in the pre and post adjuvant anti-HER-2 therapy era: a single academ

by carny

Heather M. Gage, MD, Avanti . Rangnekar. , Robert ...

Module 9: HER2-Positive and

Module 9: HER2-Positive and

by norah

Triple-Negative Breast Cancer. Jamie Carroll, APRN...

Management of HER2 Over-Expressed Breast Cancer in the Adjuvant, Neoadjuvant, and Metastatic settings

Management of HER2 Over-Expressed Breast Cancer in the Adjuvant, Neoadjuvant, and Metastatic settings

by marina-yarberry

Management of HER2 Over-Expressed Breast Cancer i...

Updates on the Use of Adjuvant Therapy in HER2-Positive Breast Cancer

Updates on the Use of Adjuvant Therapy in HER2-Positive Breast Cancer

by danika-pritchard

ASCO-CAP Recommendations For HER2 Testing in Brea...

HER2 TESTING IN BREAST CANCER

HER2 TESTING IN BREAST CANCER

by danika-pritchard

Clinical Practice Guideline Update. American Soci...

Metastatic HER2-Positive Breast Cancer: Treatment Selection

Metastatic HER2-Positive Breast Cancer: Treatment Selection

by test

First . Line and Beyond. Moderator:. Joseph Gligo...

HER2 TESTING IN BREAST CANCER

HER2 TESTING IN BREAST CANCER

by danika-pritchard

Clinical Practice Guideline Update. American Soci...

Her2 + Breast Cancer Laura

Her2 + Breast Cancer Laura

by ximena

Bidstrup. Mrs B is a 49 . yo. woman who attended ...

Nanotek & Expo 2014

Nanotek & Expo 2014

by DaintyLittlePrincess

Biodegradable . nanobrushes. for drug delivery. ...

Metastatic Breast Cancer: A Medical Update

Metastatic Breast Cancer: A Medical Update

by liane-varnes

Jennifer M. Matro, MD. Rena Rowan Breast Center. ...

Snyder D, Heidel RE, Panella T, Bell J, Orucevic

Snyder D, Heidel RE, Panella T, Bell J, Orucevic

by Kingslayer

A. University of Tennessee Medical Center – Knox...

6'DakoHercepTestTM for the Dako AutostainerCode K52071st editionFor im

6'DakoHercepTestTM for the Dako AutostainerCode K52071st editionFor im

by katrgolden

Contents PageIntended Use 4Summary and Explanation...

Product Pipeline Neratinib

Product Pipeline Neratinib

by coursion

across the breast cancer therapy spectrum. Phase I...

Endocrine resistance: molecular pathways and rational development of targeted therapies

Endocrine resistance: molecular pathways and rational development of targeted therapies

by spottletoefacebook

Grazia Arpino. Università di Napoli Federico II. ...

Updates in the Treatment of Breast cancer

Updates in the Treatment of Breast cancer

by alexa-scheidler

Mohammad . Jahanzeb. , MD, FACP. Professor of Cli...

Tumor Marker Phenotype Concordance in Second Primary Breast Cancer

Tumor Marker Phenotype Concordance in Second Primary Breast Cancer

by debby-jeon

Monica Brown, MPH, PhD. . California Cancer Regi...

ID DB06366 CATEGORY

ID DB06366 CATEGORY

by luanne-stotts

Monoclonal antibodies . PERTUZUMAB . 148 . kDa. ...

by tawny-fly

Gradishar. . MD, FACP. Betsy . Bramsen. Profess...

What’s new in Anatomic Pathology Quality Assurance?

What’s new in Anatomic Pathology Quality Assurance?

by alida-meadow

. Raouf E. Nakhleh, MD. Mayo Clinic Florida. Dis...

Central Asian Journal of

Central Asian Journal of

by cady

15 Medical and Pharmaceutical Sciences Innovation ...

Metastatic triple-positive

Metastatic triple-positive

by marcos147

breast. . cancer. . needs. . different. . ther...

Mauricio Lema Medina – Clínica de Oncología Astorga / Clínica SOMA, Medellín

Mauricio Lema Medina – Clínica de Oncología Astorga / Clínica SOMA, Medellín

by delcy

Trastuzumab-emtansine. : A . very. . nice. . poi...

Module 9: HER2-Positive and Triple-Negative BC

Module 9: HER2-Positive and Triple-Negative BC

by unita

Percent with Patients. Number of Patients (Median)...

2020 Year in Review: Breast Cancer

2020 Year in Review: Breast Cancer

by caroline

Lisa A. Carey MD, . ScM. University of North Carol...

Changes in Breast Cancer Reports After Second Opinion

Changes in Breast Cancer Reports After Second Opinion

by unita

Dr. Vicente Marco. Department of Pathology. Hospit...

ORIGINALARTICLEBREASTONCOLOGY

ORIGINALARTICLEBREASTONCOLOGY

by emery

SentinelLymphNodeBiopsyAfterNeoadjuvantChemotherap...

CA BREAST D r S ana

CA BREAST D r S ana

by oconnor

ishtiaq. . FCPS R3 general surgery unit one UKSO...

Denise A. Yardley, MD Sarah Cannon Research Institute

Denise A. Yardley, MD Sarah Cannon Research Institute

by lily

Senior Investigator, . Breast Cancer Research. Ten...

Antibody–Drug Conjugates: Practical Considerations and Applications in Clinical Use

Antibody–Drug Conjugates: Practical Considerations and Applications in Clinical Use

by gelbero

Sara A. Hurvitz, MD, FACP. Professor of Medicine. ...

Antibody–Drug Conjugates

Antibody–Drug Conjugates

by wang

in Development for . Breast Cancer. Sara A. Hurvit...

Antibody–Drug Conjugates in Development for Non-

Antibody–Drug Conjugates in Development for Non-

by elizabeth

s. mall Cell . Lung Cancer. , Gastric Cancer, and ...

TARGETED CANCER THERAPY IN 2016:

TARGETED CANCER THERAPY IN 2016:

by bagony

WHAT THE PRACTICING PATHOLOGIST OR ONCOLOGIST NEED...

Eribulin Mesylate + Trastuzumab

Eribulin Mesylate + Trastuzumab

by easyho

as First-Line Therapy for Locally Recurrent or . M...

A case of localized breast cancer

A case of localized breast cancer

by envrrolex

Antonella Brunello . Kwok-Leung Cheung. Disclosure...

Brea st cancer G eneral

Brea st cancer G eneral

by slayrboot

. in. f. orma. t. ion. Risk. . f. a. ct. ors. Pro...

Moving Evidence into Practice: Breast Cancer Highlights From Chicago

Moving Evidence into Practice: Breast Cancer Highlights From Chicago

by alida-meadow

This program will include a discussion of off-lab...

Endocrine Treatment of Metastatic Breast Cancer: New Advances; Patient Education Implications

Endocrine Treatment of Metastatic Breast Cancer: New Advances; Patient Education Implications

by calandra-battersby

An Interactive Oncology Grand Rounds Series. Joyc...

CDK 4/6 Inhibitors in Breast Cancer Expert Perspectives on New Data

CDK 4/6 Inhibitors in Breast Cancer Expert Perspectives on New Data

by min-jolicoeur

CDK 4/6 Inhibitors in Breast Cance...

Neoadjuvant Target Therapy in Her-2 Positive Breast Cancer

Neoadjuvant Target Therapy in Her-2 Positive Breast Cancer

by faustina-dinatale

Dr. . Khaled Abulkhair, PhD. Medical Oncology SCE...